Xing Lv

3.3k total citations
83 papers, 1.2k citations indexed

About

Xing Lv is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xing Lv has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Otorhinolaryngology, 38 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xing Lv's work include Head and Neck Cancer Studies (49 papers), Lung Cancer Treatments and Mutations (13 papers) and Head and Neck Surgical Oncology (13 papers). Xing Lv is often cited by papers focused on Head and Neck Cancer Studies (49 papers), Lung Cancer Treatments and Mutations (13 papers) and Head and Neck Surgical Oncology (13 papers). Xing Lv collaborates with scholars based in China, United States and Hong Kong. Xing Lv's co-authors include Xiang Guo, Wei‐Xiong Xia, Yan‐Qun Xiang, Liang‐Ru Ke, Hu L, Ya‐Hui Yu, Wen‐Ze Qiu, Huiqin Xu, Guoying Liu and Yan‐Fang Ye and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xing Lv

78 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xing Lv China	22	471	433	284	270	225	83	1.2k
Amritha Suresh India	24	501 1.1×	349 0.8×	544 1.9×	153 0.6×	187 0.8×	74	1.6k
Jia‐Wei Lv China	21	302 0.6×	347 0.8×	708 2.5×	208 0.8×	208 0.9×	50	1.5k
Zixian Wang China	28	200 0.4×	760 1.8×	921 3.2×	411 1.5×	579 2.6×	111	2.4k
Wei‐Fan Chiang Taiwan	22	161 0.3×	282 0.7×	577 2.0×	68 0.3×	91 0.4×	45	1.3k
Feng Li China	27	121 0.3×	707 1.6×	583 2.1×	466 1.7×	681 3.0×	152	2.5k
Madan Lal Brahma Bhatt India	20	77 0.2×	259 0.6×	556 2.0×	147 0.5×	154 0.7×	79	1.1k
Minsu Kwon South Korea	20	167 0.4×	222 0.5×	293 1.0×	224 0.8×	161 0.7×	63	991
Xuesong Jiang China	16	183 0.4×	212 0.5×	294 1.0×	150 0.6×	196 0.9×	40	779
Chih‐Jung Chen Taiwan	26	73 0.2×	527 1.2×	748 2.6×	374 1.4×	264 1.2×	113	2.0k

Countries citing papers authored by Xing Lv

Since Specialization

Citations

This map shows the geographic impact of Xing Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Lv more than expected).

Fields of papers citing papers by Xing Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Lv. The network helps show where Xing Lv may publish in the future.

Co-authorship network of co-authors of Xing Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Lv. A scholar is included among the top collaborators of Xing Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Lv. Xing Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hui, Lu Wang, Gui‐Rong Li, et al.. (2025). Acacetin reverses hypoxic pulmonary hypertension by inhibiting hypoxia-induced proliferation of pulmonary artery smooth muscle cells via SIRT1-HMGB1 pathway. European Journal of Pharmacology. 998. 177650–177650.

Deng, Yishu, Yingying Huang, Haijun Wu, et al.. (2025). Establishment of a deep-learning-assisted recurrent nasopharyngeal carcinoma detecting simultaneous tactic (DARNDEST) with high cost-effectiveness based on magnetic resonance images: a multicenter study in an endemic area. Cancer Imaging. 25(1). 39–39.

Huang, Kewu, Hanping Shi, Susan S. Huang, et al.. (2025). Improving Asthma Management and Patient Outcomes in China Through a Quality Improvement Programme: A Multi-centre, Single-arm Study (CARE4ALL). American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5254–A5254.

Cao, Xun, Han-Ying Huang, Jiayu Zhou, et al.. (2025). Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. Clinical Cancer Research. 31(15). 3133–3141. 1 indexed citations

Cao, Xun, Jiayu Zhou, Xi Chen, et al.. (2024). Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature Communications. 15(1). 949–949. 5 indexed citations

Chen, Qiuyan, Hai‐Qiang Mai, Shan-Shan Guo, et al.. (2024). Induction-concurrent versus concurrent-adjuvant chemoradiotherapy in patients with high-risk N2–3 nasopharyngeal carcinoma: An open-label, randomised, controlled, phase 3 trial.. Journal of Clinical Oncology. 42(16_suppl). 6072–6072. 1 indexed citations

Hong, Hanyu, Yujing Li, Junyi Zhang, et al.. (2023). An albumin-binding lidamycin prodrug for efficient targeted cancer therapy. Journal of Drug Delivery Science and Technology. 91. 105213–105213. 1 indexed citations

Huang, Yingying, et al.. (2023). Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma. Cancer Medicine. 12(13). 14084–14093. 2 indexed citations

Zhang, Junyi, et al.. (2023). mPEG-PDLLA polymeric micelles loading a novel pyridazinone derivative IMB5036 for improving anti-tumor activity in hepatocellular carcinoma. Journal of Drug Delivery Science and Technology. 90. 105101–105101. 2 indexed citations

10.

Zhou, Jiayu, Ruoyu Wang, Yingying Huang, et al.. (2023). AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma. Cancers. 15(24). 5789–5789. 4 indexed citations

11.

Lv, Xing, et al.. (2023). IMB5036 overcomes resistance to multiple chemotherapeutic drugs in human cancer cells through pyroptosis by targeting the KH-type splicing regulatory protein. Life Sciences. 328. 121941–121941. 8 indexed citations

12.

Huang, Yingying, Jiayu Zhou, Liang‐Ru Ke, et al.. (2023). Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose. BMC Cancer. 23(1). 410–410. 2 indexed citations

13.

Chen, Xi, Yingxue Li, Xun Cao, et al.. (2023). Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma. Lipids in Health and Disease. 22(1). 81–81. 5 indexed citations

14.

Deng, Yishu, Yingying Huang, Bingzhong Jing, et al.. (2023). Deep learning-based recurrence detector on magnetic resonance scans in nasopharyngeal carcinoma: A multicenter study. European Journal of Radiology. 168. 111084–111084. 4 indexed citations

15.

Huang, Yingying, et al.. (2022). Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China. Laryngoscope Investigative Otolaryngology. 7(6). 1881–1892. 4 indexed citations

16.

Chen, Dongni, Wen‐Ze Qiu, Yingying Huang, et al.. (2022). Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis. Journal of Cancer Research and Clinical Oncology. 149(6). 2327–2344. 10 indexed citations

17.

Wang, Lin, Jingjing Miao, Boyu Chen, et al.. (2021). Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up. Cancer Research and Treatment. 54(1). 118–129. 18 indexed citations

18.

Wang, Huijun, et al.. (2019). UPLC–Q‐TOF/MS characterization of efficacy substances on osteoblasts differentiation and function in rat serum after administration of Wang‐Bi tablet. Biomedical Chromatography. 33(10). e4628–e4628. 3 indexed citations

19.

Lv, Gaohong, et al.. (2016). Effect of morroniside on glomerular mesangial cells through AGE–RAGE pathway. Human Cell. 29(4). 148–154. 15 indexed citations

20.

Lv, Xing, et al.. (2012). Multi-attribute Negotiation Model Based on Artificial Immune Algorithm. Jisuanji gongcheng. 38(7). 139–141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact